Related Experiment Video
Updated: Jan 14, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Developing a Discrete Choice Experiment Instrument for Evaluating Patients' Preferences in Precision Oncology
Zahra Karimi Majd1, Nazila Yousefi1, Mohammad Peikanpour1
1Department of Pharmacoeconomics and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Patient preferences for precision oncology are crucial. A validated instrument identified key factors like treatment access, costs, life expectancy gains, and quality of life improvements for personalized medicine.
Area of Science:
- Oncology
- Health Economics
- Patient-Centered Care
Background:
- Patient preferences are vital for evaluating precision medicine (PM) interventions alongside clinical and technical factors.
- Understanding patient priorities is key to successful implementation of personalized oncology.
Purpose of the Study:
- To identify and prioritize patient-important attributes in precision oncology.
- To develop and validate a standardized stated preference instrument for assessing patient preferences in precision oncology.
Main Methods:
- Systematic literature review to extract key attributes of precision oncology.
- Delphi method with 35 experts using a Likert scale questionnaire for attribute prioritization.
- Development and validation of a discrete choice experiment (DCE) instrument based on prioritized attributes.
Main Results:
- A consensus-based DCE instrument was developed, including four attributes and 14 levels.
- Key attributes identified: treatment accessibility, out-of-pocket expenditures, changes in life expectancy, and changes in quality of life.
- The instrument provides a robust measure for evaluating patient preferences in precision oncology.
Conclusions:
- The developed DCE questionnaire reflects the main preferences of Iranian experts regarding precision oncology.
- This validated instrument can be utilized to assess patient preferences and willingness to pay (WTP) in precision oncology settings.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bioavailability Study Design: Healthy Subjects Versus Patients

